CGEM

Cullinan Therapeutics, Inc.

Healthcare›Medical - Pharmaceuticals|NASDAQ Global Select|US

Price

$14.43

Market Cap

$873.39M

Beta

-0.16

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+0.00%

EPS Growth (YoY)-19.17%

Revenue CAGR 3Y+0.00%

P/E Ratio0.0

PEG Ratio—

FCF Yield-15.90%

Debt / Equity0.01

Interest Coverage999.0x

No credit card required

Already have an account? Sign in to view the full analysis for CGEM.